Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9092c90fd86471f706dcc2ab78cb6295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63f293fb56e28b0c797fd31eb8c33ad4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de2584bef6b987ea987eb0bcc8d95afa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de8ac59362ab9f951b3381ed4680a070 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f4f46129e80ef907c188099adbb95a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-25 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
filingDate |
2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35442beb0e41ce204b300db33ec15a08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8969df730edae29854870464b3f7a22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d04e0783f02884e583a809dd2a1b43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b2b26f951408addae72f504de423ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62b643310486dabe54732473dcf59f2f |
publicationDate |
2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2937084-A1 |
titleOfInvention |
Method for the treatment of hypercholesterolemia |
abstract |
Disclosed is a therapeutic management method of hypercholesterolemia in mammals. More specifically, the present invention relates to a method of reducing high levels of circulating cholesterol (hypercholesterolemia) in the blood stream of mammals, said method involving step of administering therapeutically effective amounts of Calebin A to said mammals to bring about the effects of (i) reducing the amount of total blood cholesterol levels; (ii) reducing the concentrations of low density lipoproteins (LDL) and very low density lipoproteins (VLDL); (iii) increasing the concentrations of high density lipoproteins (HDL) and (iv) reducing concentrations of serum triglycerides. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3085370-A1 |
priorityDate |
2014-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |